The BLA Antibody (PACO34602) is a specialized tool for researchers studying the BLA protein, an essential component in immune responses and immune regulation. This polyclonal antibody, generated in rabbits, exhibits high reactivity with human samples and has been rigorously validated for Western blot applications. By binding to the BLA protein, this antibody allows for precise detection and analysis in various cell types, making it an invaluable asset for investigations in immunology and cancer research.
BLA, also known as B-lymphocyte activation marker, plays a crucial role in modulating immune responses and maintaining immune balance. Its involvement in immune function makes it a key target for exploration in diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. Uncovering the mechanisms of BLA activity is vital for the development of novel therapeutic strategies that manipulate immune responses to combat these diseases effectively.
Antibody Name:
bla Antibody (PACO34602)
Antibody SKU:
PACO34602
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA
Recommended Dilutions:
Species Reactivity:
Escherichia coli
Immunogen:
Recombinant Escherichia coli Beta-lactamase TEM protein (24-286AA)
TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
